In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

During the COVID-19 pandemic, healthcare workers faced several mental health challenges, experiencing repeated exposure to ...

An intervention program that coaches patients in stress management and goal setting, along with a digital app, helped ...

Gene therapies have a lot of potential to improve health outcomes for patients with life-threatening diseases but face a ...

Lindsay Bealor Greenleaf, JD, MBA; Ryann Hill, MPH; Patrick Cooney ...

After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked ...

President-elect Donald Trump announced last Thursday, Nov. 14, that Kennedy, 70, was his pick to head the Department of ...

The FDA has approved UCB's Bimzelx for moderate-to-severe hidradenitis suppurativa, offering a new treatment option for this ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

In a recent conversation with Greg Baker, CEO of AffirmedRx, the PBM professional outlined the company’s distinct approach in the PBM industry with MHE editors.

Monjuvi is available under an accelerated approval to treat adults with relapsed or refractory diffuse large B-cell lymphoma.

A total of 17 lots are now part of the recall of Clonazepam because some cartons have the wrong strength on the label.